The Next Chapter of Oncology Pathways: AI, Transparency, and What’s Next скачать в хорошем качестве

The Next Chapter of Oncology Pathways: AI, Transparency, and What’s Next

In this episode of the Only Healthcare Podcast, host Randy Vogenberg, PhD, sits down with consultant and longtime oncology pathways leader Gordon Kuntz to reflect on the evolution of the Clinical Pathways Congress and a groundbreaking new initiative on the predictable cost of care in oncology. Gordon shares how oncology pathways have matured over the last two decades, why Congress has shifted from purely clinical topics to a stronger focus on business and operations, and how artificial intelligence is transitioning from theory to practical application in cancer centers. The conversation then dives into the multi-year effort to build a Predictable Cost of Care model for oncology treatment decisions, recently published in the Journal of Clinical Pathways. Gordon explains why traditional pathway cost inputs have focused almost exclusively on drug costs, why that is no longer sufficient, and how this new framework aims to capture a more comprehensive picture of predictable costs across drugs, administration, side effect management, and patient touchpoints. The episode closes with a look at governance, metrics, and the broader value of this model for payers, providers, oncology practices, and employer plan sponsors trying to bring more certainty and transparency to cancer care.